Home DailyMed be8f1c7d-fd4e-48d4-80b0-1d92a2ba6a70 anti diarrheal Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer Major Pharmaceuticals
Effective date 2025-12-06
Label type HUMAN OTC DRUG LABEL
Version 6
Source full-release
Hydrated at 2026-06-01 01:20:33 Label at a glance# Product anti diarrheal
Active ingredient LOPERAMIDE HYDROCHLORIDE
Label structure 8 sections
Dosage and administration • drink plenty of clear fluids to help prevent dehydration caused by diarrhea • find right dose on chart. If possible, use weight to dose; otherwise, use age. adults and children 12 years and over 2 caplets after the first loose stool; 1 caplet after each subsequent loose stool; but no more than 4 caplets in 24 hours children 9-11 years (60-95 lbs) 1 caplet after the first loose stool; 1/2 caplet after each subseq...
Storage and handling • store at 20 ° -25 ° C (68 ° -77 ° F) • see end panel for lot number and expiration date
DailyMed RxNorm Mappings# RxCUI, RxNorm string, TTY table RxCUI RxNorm string TTY SPL version 978010 loperamide HCl 2 MG Oral Tablet PSN 6 978010 loperamide hydrochloride 2 MG Oral Tablet SCD 6
DailyMed Pharmacologic Classes# DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0904-7725-12 anti diarrheal 1 in 1 BLISTER PACK TABLET, FILM COATED 1 6 0904-7725-12 anti diarrheal 12 in 1 CARTON TABLET, FILM COATED 12 6 0904-7725-24 anti diarrheal 24 in 1 CARTON TABLET, FILM COATED 24 6 0904-7725-24 anti diarrheal 1 in 1 BLISTER PACK TABLET, FILM COATED 1 6
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII SPL version Uploaded LOPERAMIDE HYDROCHLORIDE ACTIVE INGREDIENT 77TI35393C 2 LOPERAMIDE ACTIVE MOIETY 6X9OC3H4II 2 ANHYDROUS LACTOSE INACTIVE INGREDIENT 3SY5LH9PMK 2 CARNAUBA WAX INACTIVE INGREDIENT R12CBM0EIZ 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U 2 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G 2 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD 2 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 2 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ 2
Products# Every source-derived product name is available through these pages.
DailyMed product names page 1 of 1 · 11 matching rows.
anti diarrheal Loperamide Hydrochloride LOPERAMIDE ANHYDROUS LACTOSE CARNAUBA WAX D&C YELLOW NO. 10 ALUMINUM LAKE FD&C BLUE NO. 1 ALUMINUM LAKE HYPROMELLOSE, UNSPECIFIED MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL, UNSPECIFIED Ingredients# Every source-derived ingredient row is available through these pages.
DailyMed ingredient rows page 1 of 1 · 9 matching rows.
Older Hydrated Versions# Version, Effective date, Source table Version Effective date Source Hydrated 5 2022-11-10 full-release 2026-05-31 23:51:29
Inactive ingredient matches# Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
Inactive ingredient links page 1 of 1 · 24 matching rows.
DailyMed ingredient, IID ingredient, UNII table DailyMed ingredient IID ingredient UNII Dosage form / route Potency Maximum daily exposure Match MAGNESIUM STEARATE MAGNESIUM STEARATE 70097M6I30 TABLET, FILM COATED / ORAL 96 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates MAGNESIUM STEARATE MAGNESIUM STEARATE 70097M6I30 TABLET, FILM COATED / ORAL 96 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates HYPROMELLOSES HYPROMELLOSE 3NXW29V3WO TABLET, FILM COATED / ORAL 582 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates ANHYDROUS LACTOSE ANHYDROUS LACTOSE 3SY5LH9PMK TABLET, FILM COATED / ORAL 2906 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates MAGNESIUM STEARATE MAGNESIUM STEARATE 70097M6I30 TABLET, FILM COATED / ORAL 96 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates ANHYDROUS LACTOSE ANHYDROUS LACTOSE 3SY5LH9PMK TABLET, FILM COATED / ORAL 2906 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates CARNAUBA WAX CARNAUBA WAX R12CBM0EIZ TABLET, FILM COATED / ORAL 1 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates FD&C BLUE NO. 1 FD&C BLUE NO. 1 H3R47K3TBD TABLET, FILM COATED / ORAL 0.16 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates CELLULOSE, MICROCRYSTALLINE MICROCRYSTALLINE CELLULOSE OP1R32D61U TABLET, FILM COATED / ORAL 992 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates FD&C BLUE NO. 1 FD&C BLUE NO. 1 H3R47K3TBD TABLET, FILM COATED / ORAL 0.16 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates D&C YELLOW NO. 10 D&C YELLOW NO. 10 35SW5USQ3G TABLET, FILM COATED / ORAL 120 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates FD&C BLUE NO. 1 FD&C BLUE NO. 1 H3R47K3TBD TABLET, FILM COATED / ORAL 0.16 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates HYPROMELLOSES HYPROMELLOSE 3NXW29V3WO TABLET, FILM COATED / ORAL 582 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates STARCH, CORN STARCH, CORN O8232NY3SJ TABLET, FILM COATED / ORAL 2000 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates HYPROMELLOSES HYPROMELLOSE 3NXW29V3WO TABLET, FILM COATED / ORAL 582 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates CARNAUBA WAX CARNAUBA WAX R12CBM0EIZ TABLET, FILM COATED / ORAL 1 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates STARCH, CORN STARCH, CORN O8232NY3SJ TABLET, FILM COATED / ORAL 2000 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates CELLULOSE, MICROCRYSTALLINE MICROCRYSTALLINE CELLULOSE OP1R32D61U TABLET, FILM COATED / ORAL 992 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates D&C YELLOW NO. 10 D&C YELLOW NO. 10 35SW5USQ3G TABLET, FILM COATED / ORAL 120 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates ANHYDROUS LACTOSE ANHYDROUS LACTOSE 3SY5LH9PMK TABLET, FILM COATED / ORAL 2906 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates STARCH, CORN STARCH, CORN O8232NY3SJ TABLET, FILM COATED / ORAL 2000 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates CELLULOSE, MICROCRYSTALLINE MICROCRYSTALLINE CELLULOSE OP1R32D61U TABLET, FILM COATED / ORAL 992 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates CARNAUBA WAX CARNAUBA WAX R12CBM0EIZ TABLET, FILM COATED / ORAL 1 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates D&C YELLOW NO. 10 D&C YELLOW NO. 10 35SW5USQ3G TABLET, FILM COATED / ORAL 120 mg Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A075232-001 LOPERAMIDE HYDROCHLORIDE LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 84e616aacf4f…2026-08-18 06:07:40 2026-07 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A075232-001 LOPERAMIDE HYDROCHLORIDE 2MG TABLET / ORAL 2000-01-06 f41ea6bd6efb…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.